Pharmafile Logo

Dedicated

- PMLiVE

Change at the top as Levin leaves Teva

CEO resigns amid company-wide restructure

- PMLiVE

Janssen submits blood cancer drug in EU

Seeks EMA approval for ibrutinib

- PMLiVE

Former Ketchum head joins Luther Pendragon

Avril Lee becomes director at the corporate communications consultancy

- PMLiVE

AZ takes severe asthma antibody into phase III

Benralizumab shows promise in clinical trials

Shire appoints finance-focused board member

Dominic Blakemore is group finance director of Compass Group

- PMLiVE

FDA raises awareness of misleading drug ads

E-learning course to help HCPS and students learn how to report untruthful promotion

- PMLiVE

Driving good practice in homecare

The release of new professional standards looks to underpin the quality, and continued rise, of homecare services in the UK

- PMLiVE

Havas’ UK Nurofen campaign to cost £3m

Reckitt Benckiser rolls out TV advertisements in time for flu and cold season

Sanofi reception

Sanofi returns to growth in Q3

Diabetes products and Genzyme help company overcome patent cliff

- PMLiVE

Pfizer sales down but oncology shows promise

Toll of patent expiries continues

- PMLiVE

Incivek decline forces Vertex job cuts

370 positions to be axed

Pfizer’s Paul Haley joins bmore Creative

He is appointed strategy director

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links